BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bio-PAT - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bio-PAT
X-ORIGINAL-URL:https://bio-pat.org
X-WR-CALDESC:Veranstaltungen für Bio-PAT
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230612T150000
DTEND;TZID=Europe/Paris:20230612T160000
DTSTAMP:20260619T192639
CREATED:20230609T134657Z
LAST-MODIFIED:20230609T134909Z
UID:9467-1686582000-1686585600@bio-pat.org
SUMMARY:FyoniBio Webinar - Explore the future of biopharmaceutical cell line development!
DESCRIPTION:FyoniBio Webinar: Alone but Not Lonely: Designing an Outgrowth-Promoting Environment for Single Cell Cloning 9:00am EDT / 2:00pm BST / 3:00pm CEST \n\n\n\n\n\n\n\nIn the frame of the BioProcess International Spring Digital Week\, Vicky Goralczyk and Lena Thoring\, Directors of Cell Line and Bioprocess Development at FyoniBio GmbH\, offer you to explore the future of biopharmaceutical cell line development. \n\n\n\nInformation & Registration \n\n\n\n\n\n\n\nAbstract \n\n\n\nDoing things quickly has become a paradigm in biopharma development. Simultaneously\, in early development\, variability is required to extract the most data and increase chances of success. This leads to a demand in high-throughput\, automated techniques\, and highly skilled professionals. Risk taking and early adoption of new techniques is part of innovation to optimize workflows\, especially when projects are highly individual and cannot follow standard routines. In clone development\, this includes working with very different host cell lines\, customized protocols\, and unforeseen circumstances which needs adaptable processes and multifunctional devices. \n\n\n\nThis webinar will present data on how the CellCelector platform can effectively be used for cell line development\, host cell engineering\, and cell adaptation and how it was successfully integrated into FyoniBio‘s platform for development of biopharmaceutics.for autologous and allogeneic cell therapies. After viewing this session\, participants will have a better understanding of: \n\n\n\nHow to identify key development and manufacturing challengesCommercial scalability strategies for late-stage cell therapiesWays to drive innovation to accelerate the delivery of cell therapies to patients fasterHow\, when and why to leverage state-of-the-art facilitiesThe importance of end-to-end supply chain management\n\n\n\nSpeaker:  \n\n\n\nVicky Goralczyk\, PhDDirector of Cell Line and Bioprocess Development at FyoniBio GmbH (a Bio-PAT member)
URL:https://bio-pat.org/event/fyonibio-webinar
LOCATION:Venue: Online
ATTACH;FMTTYPE=image/jpeg:https://bio-pat.org/wp-content/uploads/2023/06/FyoniWebinar.jpg
END:VEVENT
END:VCALENDAR